Rewind: Roche returns to phase 2 after seeing post hoc signal in failed pivotal Huntington’s trial
Rewind: Roche returns to phase 2 after seeing post hoc [...]
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna Chair Noubar Afeyan pens first annual letter
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna [...]
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna Chair Afeyan pens first annual letter
‘Shots on goal’ to ‘deterministic’ drug development: Flagship CEO, Moderna [...]
FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish
FDA approval, global partnership on the agenda at Mithra as [...]
EMA sets out plan to accelerate clinical trials, reduce administrative burden
EMA sets out plan to accelerate clinical trials, reduce administrative [...]
FDA denies Denali’s Takeda-partnered Alzheimer’s drug from entering clinic
FDA denies Denali’s Takeda-partnered Alzheimer’s drug from entering clinic klahucik [...]
Sarepta, with pivotal data in sight, dumps Lysogene gene therapy
Sarepta, with pivotal data in sight, dumps Lysogene gene therapy [...]
JPM22, Day 4: Vertex aims to be cystic fibrosis leader into the 2030s; Gritstone hopes for new colorectal cancer biomarker
JPM22, Day 4: Vertex aims to be cystic fibrosis leader [...]
JPM22, Day 4: Galapagos plots rebound with M&A, new CEO; Gritstone hopes for new cancer biomarker; Vertex’s cystic fibrosis dominance
JPM22, Day 4: Galapagos plots rebound with M&A, new CEO; [...]
AstraZeneca pays Hoos-helmed Scorpion $75M to take the sting out of undruggable cancer targets
AstraZeneca pays Hoos-helmed Scorpion $75M to take the sting out [...]